Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
92.09
+0.68 (0.74%)
At close: Mar 6, 2026, 4:00 PM EST
95.88
+3.79 (4.12%)
After-hours: Mar 6, 2026, 6:00 PM EST
Protagonist Therapeutics Market Cap
Protagonist Therapeutics has a market cap or net worth of $5.88 billion as of March 6, 2026. Its market cap has increased by 155.90% in one year.
Market Cap
5.88B
Enterprise Value
5.24B
1-Year Change
155.90%
Ranking
Category
Stock Price
$92.09
Market Cap Chart
Since August 11, 2016, Protagonist Therapeutics's market cap has increased from $171.50M to $5.88B, an increase of 3,326.32%. That is a compound annual growth rate of 44.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 5.83B | 6.83% |
| Dec 31, 2025 | 5.46B | 137.34% |
| Dec 31, 2024 | 2.30B | 73.94% |
| Dec 29, 2023 | 1.32B | 146.39% |
| Dec 30, 2022 | 536.80M | -67.11% |
| Dec 31, 2021 | 1.63B | 111.63% |
| Dec 31, 2020 | 771.30M | 302.14% |
| Dec 31, 2019 | 191.80M | 17.81% |
| Dec 31, 2018 | 162.80M | -61.78% |
| Dec 29, 2017 | 426.00M | 15.89% |
| Dec 30, 2016 | 367.60M | 114.34% |
| Aug 11, 2016 | 171.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kymera Therapeutics | 6.66B |
| Belite Bio | 6.50B |
| Rhythm Pharmaceuticals | 6.28B |
| Cogent Biosciences | 5.94B |
| Caris Life Sciences | 5.34B |
| Celcuity | 5.32B |
| Immunovant | 5.30B |
| CRISPR Therapeutics AG | 5.29B |